Scientists at Tel Aviv University and the Israel Institute for Biological Research have developed the first mRNA vaccine proven completely effective against deadly bacteria. This groundbreaking ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

But promising results from a small clinical trial for an mRNA pancreatic cancer vaccine are fueling new rays of hope. “The latest data from the Phase I trial are encouraging,” said lead author ...

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...

A recent study found that mRNA-based vaccines may help to delay the recurrence of pancreatic cancer by generating long-lasting immune responses. The phase 1 trial results, published Feb. 19 in ...

A PDAC cell line was generated from a patient who consented to make the genetic code of her cancer cells publicly available ...

Personalized cancer vaccines may be available by 2025, with mRNA-4157 showing promising results in melanoma treatment. ELI-002 offers a novel approach for pancreatic cancer but is several years from ...

A UCLA-developed nanoparticle is aiming to reprogram the liver in humans to attack pancreatic cancer with an mRNA vaccine (curved, hatched red lines) and an immune-activating fragment of genetic ...

“The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of pancreatic cancer: hope,” Jarvis writes.

We have a mRNA personalized vaccine for pancreatic cancer,” Dr. Kim added, before heading to the operating room to remove a cancerous tumor from a patient’s pancreas.

Beyond mRNA-based diagnostic tests, mRNA has also shown early promise as a therapy for cancer patients, enabling personalized treatment that could more effectively target one’s tumor.

Pancreatic cancer is one of the deadliest cancers. But those battling the disease saw promising results in the small clinical trial of an mRNA vaccine.